DSGN (STOCKS)
Design Therapeutics, Inc. Common Stock
$14.390000
-0.270000 (-1.84%)
Prev close: $14.660000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Pratik Shah
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,035.36M
- Employees
- 55
- P/E (TTM)
- -12.42
- P/B (TTM)
- 4.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $79.36M |
| Research and Development | $58.78M |
| Other Operating Expenses | $20.58M |
| Operating Income/Loss | -$79.36M |
| Income/Loss From Continuing Operations After Tax | -$70.80M |
| Income/Loss From Continuing Operations Before Tax | -$70.80M |
| Net Income/Loss | -$70.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$70.80M |
| Net Income/Loss Available To Common Stockholders, Basic | -$70.80M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.18 |
| Diluted Earnings Per Share | -$1.18 |
| Basic Average Shares | 119,397,269 |
| Diluted Average Shares | 119,397,269 |
| Assets | $215.13M |
| Current Assets | $212.01M |
| Cash | $207.40M |
| Prepaid Expenses | $2.83M |
| Other Current Assets | $1.78M |
| Noncurrent Assets | $3.12M |
| Fixed Assets | $694.00K |
| Other Non-current Assets | $2.42M |
| Liabilities | $13.27M |
| Current Liabilities | $11.24M |
| Accounts Payable | $3.14M |
| Wages | $2.79M |
| Other Current Liabilities | $5.31M |
| Noncurrent Liabilities | $2.03M |
| Equity | $201.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $201.86M |
| Liabilities And Equity | $215.13M |
| Net Cash Flow From Operating Activities | -$55.08M |
| Net Cash Flow From Operating Activities, Continuing | -$55.08M |
| Net Cash Flow From Investing Activities | $2.39M |
| Net Cash Flow From Investing Activities, Continuing | $2.39M |
| Net Cash Flow From Financing Activities | $45.89M |
| Net Cash Flow From Financing Activities, Continuing | $45.89M |
| Net Cash Flow | -$6.80M |
| Net Cash Flow, Continuing | -$6.80M |
| Comprehensive Income/Loss | -$71.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$71.87M |
| Other Comprehensive Income/Loss | -$18.07M |